Beranda8AP • FRA
add
Agios Pharmaceuticals Inc
Tutup sebelumnya
€25,00
Rentang hari
€25,00 - €25,00
Rentang tahun
€19,70 - €38,80
Kapitalisasi pasar
1,77Â M USD
Volume Rata-Rata
3,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 19,97Â jt | 86,09% |
Biaya operasional | 51,61Â jt | -0,17% |
Penghasilan bersih | -108,04Â jt | -11,93% |
Margin laba bersih | -541,09 | 39,85% |
Penghasilan per saham | -1,85 | -6,32% |
EBITDA | -120,31Â jt | 2,72% |
Tarif pajak efektif | 0,93% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 854,42Â jt | -4,40% |
Total aset | 1,30Â M | -22,00% |
Total liabilitas | 104,11Â jt | -14,83% |
Total ekuitas | 1,19 M | — |
Saham yang beredar | 58,59 jt | — |
Harga terhadap nilai buku | 1,22 | — |
Tingkat pengembalian aset | -22,66% | — |
Tingkat pengembalian modal | -23,73% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -108,04Â jt | -11,93% |
Kas dari operasi | -96,21Â jt | 27,75% |
Kas dari investasi | 90,08Â jt | 283,24% |
Kas dari pembiayaan | 2,56Â jt | -47,19% |
Perubahan kas bersih | -3,58Â jt | 97,98% |
Arus kas bebas | -62,05Â jt | 42,58% |
Tentang
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Didirikan
2008
Situs
Karyawan
540
